Surgery Partners, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Surgery Partners, Inc. (SGRY) reported Net Income (Loss) Available to Common Stockholders, Basic of -$11.90 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-26.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2024-02-26
- Surgery Partners, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2022-12-31 was -$23.40M.
- Surgery Partners, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2022-09-30 was -$25.00M.
- Surgery Partners, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2022-06-30 was -$18.40M.
- Surgery Partners, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2022-03-31 was $12.20M.
- Surgery Partners, Inc. net income (loss) available to common stockholders, basic for fiscal 2023 was -$11.90M.
- Surgery Partners, Inc. net income (loss) available to common stockholders, basic for fiscal 2022 was -$54.60M.
- Surgery Partners, Inc. net income (loss) available to common stockholders, basic for fiscal 2021 was -$81.20M.
- Surgery Partners, Inc. net income (loss) available to common stockholders, basic for fiscal 2020 was -$155.60M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 1 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 4 month | Net Income (Loss) Available to Common Stockholders, Basic 4 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 8 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | -$11.90M 10-K · filed 2024-02-26 | |||||||||||
| 2022-12-31 | -$23.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$48.40M derived: sum of 2 quarters · filed 2024-02-26 | -$66.80M derived: sum of 3 quarters · filed 2024-02-26 | -$54.60M 10-K · filed 2024-02-26 | ||||||||
| 2022-09-30 | -$25.00M 10-Q · filed 2022-11-08 | -$43.40M derived: sum of 2 quarters · filed 2022-11-08 | -$31.20M 10-Q · filed 2022-11-08 | -$31.30M derived: sum of 4 quarters · filed 2024-02-26 | ||||||||
| 2022-06-30 | -$18.40M 10-Q · filed 2022-08-02 | -$6.20M 10-Q · filed 2022-08-02 | -$6.30M derived: sum of 3 quarters · filed 2024-02-26 | -$29.20M derived: sum of 4 quarters · filed 2024-02-26 | ||||||||
| 2022-03-31 | $12.20M 10-Q · filed 2022-05-03 | $12.10M derived: sum of 2 quarters · filed 2024-02-26 | -$10.80M derived: sum of 3 quarters · filed 2024-02-26 | -$37.70M derived: sum of 4 quarters · filed 2024-02-26 | ||||||||
| 2021-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$23.00M derived: sum of 2 quarters · filed 2024-02-26 | -$49.90M derived: sum of 3 quarters · filed 2024-02-26 | -$81.20M 10-K · filed 2024-02-26 | ||||||||
| 2021-09-30 | -$22.90M 10-Q · filed 2022-11-08 | -$49.80M derived: sum of 2 quarters · filed 2022-11-08 | -$81.10M 10-Q · filed 2022-11-08 | -$85.90M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2021-06-30 | -$26.90M 10-Q · filed 2022-08-02 | -$58.20M 10-Q · filed 2022-08-02 | -$63.00M derived: sum of 3 quarters · filed 2023-03-01 | -$134.60M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2021-03-31 | -$31.30M 10-Q · filed 2022-05-03 | -$36.10M derived: sum of 2 quarters · filed 2023-03-01 | -$107.70M derived: sum of 3 quarters · filed 2023-03-01 | -$149.90M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2020-12-31 | -$4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$76.40M derived: sum of 2 quarters · filed 2023-03-01 | -$118.60M derived: sum of 3 quarters · filed 2023-03-01 | -$155.60M 10-K · filed 2023-03-01 | ||||||||
| 2020-09-30 | -$71.60M 10-Q · filed 2021-11-03 | -$113.80M derived: sum of 2 quarters · filed 2021-11-03 | -$150.80M 10-Q · filed 2021-11-03 | -$179.30M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||
| 2020-06-30 | -$42.20M 10-Q · filed 2021-08-04 | -$79.20M 10-Q · filed 2021-08-04 | -$107.70M derived: sum of 3 quarters · filed 2022-03-01 | -$132.50M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||
| 2020-03-31 | -$37.00M 10-Q · filed 2021-05-05 | -$65.50M derived: sum of 2 quarters · filed 2022-03-01 | -$90.30M derived: sum of 3 quarters · filed 2022-03-01 | -$118.90M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||
| 2019-12-31 | -$28.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$53.30M derived: sum of 2 quarters · filed 2022-03-01 | -$81.90M derived: sum of 3 quarters · filed 2022-03-01 | -$110.50M 10-K · filed 2022-03-01 | ||||||||
| 2019-09-30 | -$24.80M 10-Q · filed 2020-11-04 | -$53.40M derived: sum of 2 quarters · filed 2020-11-04 | -$82.00M 10-Q · filed 2020-11-04 | -$238.20M derived: sum of 4 quarters · filed 2021-03-10 | ||||||||
| 2019-06-30 | -$28.60M 10-Q · filed 2020-08-05 | -$57.20M 10-Q · filed 2020-08-05 | -$213.40M derived: sum of 3 quarters · filed 2021-03-10 | -$242.60M derived: sum of 4 quarters · filed 2021-03-10 | ||||||||
| 2019-03-31 | -$28.60M 10-Q · filed 2020-05-11 | -$184.80M derived: sum of 2 quarters · filed 2021-03-10 | -$214.00M derived: sum of 3 quarters · filed 2021-03-10 | -$241.40M derived: sum of 4 quarters · filed 2021-03-10 | ||||||||
| 2018-12-31 | -$156.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$185.40M derived: sum of 2 quarters · filed 2021-03-10 | -$212.80M derived: sum of 3 quarters · filed 2021-03-10 | -$238.10M 10-K · filed 2021-03-10 | -$238.13M 10-K · filed 2019-03-15 | |||||||
| 2018-09-30 | -$29.20M 10-Q · filed 2019-11-06 | -$29.23M 10-Q · filed 2018-11-09 | -$56.60M derived: sum of 2 quarters · filed 2019-11-06 | -$81.90M 10-Q · filed 2019-11-06 | -$81.94M 10-Q · filed 2018-11-09 | |||||||
| 2018-06-30 | -$27.40M 10-Q · filed 2019-08-09 | -$27.42M 10-Q · filed 2018-08-09 | -$52.70M 10-Q · filed 2019-08-09 | -$52.71M 10-Q · filed 2018-08-09 | ||||||||
| 2018-03-31 | -$25.30M 10-Q · filed 2019-05-10 | -$25.29M 10-Q · filed 2018-05-10 | ||||||||||
| 2017-12-31 | -$67.40M 10-K · filed 2020-03-13 | -$67.36M 10-K · filed 2018-03-16 | ||||||||||
| 2017-09-30 | -$27.34M 10-Q · filed 2018-11-09 | |||||||||||
| 2017-08-31 | -$11.70M 10-K · filed 2020-03-13 | |||||||||||
| 2017-03-31 | -$2.75M 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |